Track medtech innovations from your desktop, subscribe to Innovation Hub.

Learn More

Keynote & Panels

In addition to 100 new medtech ventures, the event will also feature keynotes and panels with industry thought leaders.

Who Attended? Register for 2021

The Next Quantum Leaps in Medtech

February 19th, 2020
8:00 - 8:40am

In his keynote address, Christopher Velis, founder of Auris Health and Miraki Innovation shares insights on a repeatable process for quantum leaps of innovation. As challenges in global healthcare increase and become more urgent, momentous progress is critical. Next generation medtech companies must think beyond incremental progress while also developing lifesaving companies without missteps or delay. Auris Health was the largest medtech venture funded transaction in history, acquired by Johnson & Johnson for a total of $5.75 billion. Christopher’s method, used to develop Auris and other leading medtech companies, identifies future demands and efficiently and effectively builds the solutions to those pressing market needs. Christopher discusses the Auris story and where he sees the next big opportunities (and challenges) in medtech innovation.

Christopher J. Velis

Christopher J. Velis

Founder & Executive Chairman, Miraki Innovation

Keynote

Interview with a Medtech Legend

February 18th, 2020
7:00 - 7:30pm

Join us for a fireside chat with industry legend and prolific entrepreneur, Dr. Manny Villafaña .  We'll hear the stories and insights behind how Manny built St. Jude Medical, ATS Medical, and Cardiac Pacemakers Inc.  We'll also find out what he's up to with his next venture, Medical 21.

Manny is the co-inventor of the first lithium powered pacemaker and founder of Cardiac Pacemakers, Inc./Guidant.  He is the co-developer of the St. Jude heart valve, Founder of St. Jude Medical, Inc, co-inventor of the ATS heart valve, Founder of ATS Medical, Inc (Medtronic).  Manny currently serves as the Founder, Chairman, & CEO of Medical 21, Inc.  Dr. Villafaña is globally recognized as a “Living Legend of Medicine.”  He is an award-winning USA Master Entrepreneur, a member of the Halls of Fame of Minnesota Business and Science & Technology.  He is the past founder of medical device companies that  have transformed the industry of cardiac surgery and improved the lives of millions.  Manny is also the recipient of an honorary Doctorate of Sciences degree from the University of Iowa.

Manny Villafaña, PhD, Sc

Manny Villafaña, PhD, Sc

Founder of St. Jude Medical, ATS, Cardiac Pacemakers, Currently CEO of Medical 21

Fireside Chat

Medtech 2020: Venture Capital Outlook

February 18th, 2020
7:40 - 8:25pm

In this panel we'll talk to active VCs about the types of deals they are in now and we'll find out what new deals they are looking for in 2020.  

Dennis McWilliams

Dennis McWilliams

Venture Partner, Sante Ventures

Panelist

Jon Root

Jon Root

General Partner, US Venture Partners

Panelist

John F. Ryan

John F. Ryan

Managing Director, Wells Fargo Strategic Capital

Panelist

Janelle Goulard

Janelle Goulard

Director of Health Investment, Pangaea Ventures

Panelist

Mar Perez

Mar Perez

Principal, InCube Ventures

Panelist

Howard Levin, MD

Howard Levin, MD

Managing Partner, Coridea

Panelist

Bill Carpou

Bill Carpou

CEO, Octane

Moderator

Insights and Opinions From Big Company Executives Turned Entrepreneurs

February 19th, 2020
1:05 - 1:45pm

In this panel we’ll hear the experiences and insights from ex- big company executives who’ve chosen the entrepreneurial path and are now leading early stage medtech ventures.  We’ll have them share war stories, perspectives of being on both sides of the table, and find out what they are up to next -- and why.  The executives on this panel have held senior positions with the some of the largest medtech strategics and have multiple exits under their belts as entrepreneurs. 

Join us for an informative (and fun) discussion with panelists Jim Corbett (Boston Scientific, ev3, MicroTherapeutics, Alphatec Spine), Todd Usen (Olympus, Smith & Nephew, Boston Scientific), Brian Verrier (Covidien, Medtronic), Paul Molloy (Telefex, VasoNova, Micardia), and Tim Moran (ConvaTec, Covidien).

The panel will be moderated by industry insider and Alira Health Senior Partner & VP, David Uffer.

Jim Corbett

Jim Corbett

CEO, CathWorks

Panelist

Brian Verrier

Brian Verrier

CEO, Ossio

Panelist

Todd Usen

Todd Usen

CEO, Activ Surgical

Panelist

Timothy P. Moran

Timothy P. Moran

CEO, Motus GI

Panelist

Paul Molloy

Paul Molloy

CEO, ClearFlow

Panelist

David Uffer

David Uffer

Senior Partner & VP, Alira Health

Moderator

The Strategic Outlook on Medtech Deal-Making

February 19th, 2020
11:30am - 12:10pm

In this panel we'll get insights from leading medtech strategics J&J, Medtronic, Terumo, and Intuitive Surgical.  We will discuss the types of deals they are looking for and have each stakeholder weigh in on deal structure trends and provide a perspective on where they see M&A in 2020 and beyond.    

We will also learn about an important global strategic partnership formed in 2019 between Terumo & Orchestra BioMed and how this innovative approach to risk/reward sharing for product development and commercialization might shape future deal-making opportunities for strategics and innovators.

 

James Rushworth

James Rushworth

CEO, Terumo Medical Corporation

Panelist

Nicholas Pachuda

Nicholas Pachuda

WW VP, Orthopedic Innovation, J&J Medical Devices

Panelist

Julian Nikolchev

Julian Nikolchev

Senior VP Corporate Development & Strategy, Intuitive Surgical

Panelist

David Hochman

David Hochman

Chairman & CEO, Orchestra BioMed

Panelist

Earl Slee

Earl Slee

VP, Technology, Strategy & Business Development, Medtronic

Panelist

Dave Mildrew

Dave Mildrew

Managing Director, BioQuest

Moderator

2020: Hot Topics in Clinical Affairs

February 20th, 2020
Noon - 1pm

Saving money, speeding enrollment and generating real world evidence in clinical studies.  Hear from industry experts, Ori Ben-Yehuda, MD, Tonya Dowd & Lisa Beck, about how to efficiently manage a clinical trial and generate real world evidence to support reimbursement and regulatory decisions.

This panel discussion will be hosted by MCRA and will run during a lunch session.  Space is limited. To reserve your spot, please RSVP here.

 

 

 

Lisa Beck

Lisa Beck

Director, Clinical Affairs, MCRA

Moderator

Ori Ben-Yehuda

Ori Ben-Yehuda

Executive Director, Cardiovascular Research Foundation

Panelist

Tonya Dowd

Tonya Dowd

Vice President, MCRA

Panelist

Early Reimbursement & Market Access Planning: Not Optional

February 18th, 2020
Noon - 1:00pm

In this panel we'll get a "from the trenches" perspective on reimbursement and market access strategies directly from the key stakeholders; the CEO, Strategic Investor, Venture Capitalist, and Payer.  This group will share their insights and experiences (some positive, some painful) on why having a proper reimbursement and market access strategy is so critical. 

The panel will be moderated by medtech industry veteran and reimbursement thought leader, Tonya Dowd.  Tonya is MCRA's Vice President of Reimbursement, Health Economics and Market Access.

Terri Burke

Terri Burke

Venture Partner, Epidarex Capital

Insights from the VC

Lisa Wipperman Heine

Lisa Wipperman Heine

CEO, PreCardia

Insights from the CEO

Tonya Dowd

Tonya Dowd

Vice President, MCRA

Moderator

Gary Owens, M.D.

Gary Owens, M.D.

Medical Director, Former Payer

Insights from the Payer

Non-Traditional VC, Family Office, Angel & CrowdSourcing in 2020

February 20th, 2020
1:05 - 1:45pm

In this panel we’ll hear from active medtech angels, family office, and other non-traditional early stage investors.  What are they investing in?  What are they bringing to the table besides capital?  What kind of deals are they interested in right now? 

This group of panelists represent a new CrowdSourcing & Direct Investment Platform, 4 Lifescience Angel Groups, 2 Family Offices, and a new VC fund focused exclusively on early-stage deals.

Rob Ball

Rob Ball

Managing Director, Genesis & CultivateMD Fund

Panelist

Greg Scott

Greg Scott

Co-Founder, BioPacific Investors, Chairman, ChinaBio Group

Panelist

Brian Smith

Brian Smith

CEO, RedCrow, Direct Investment Platform

Panelist

Ben Joseph

Ben Joseph

President, Mend Medical

Panelist

Irfan Lateef

Irfan Lateef

Partner, Knobbe Martens

Moderator

David Hood

David Hood

President, DH3 & Associates

Panelist

Health Economics and Outcomes Research (HEOR): From Concept to Implementation

February 20th, 2020
11:20am - 12:00pm

This panel will introduce the audience to Health Economics and Outcomes Research (HEOR) fundamentals, how HEOR strategies can be implemented at the different stages of product development, and how to use HEOR to drive value at each stage of the development lifecycle.

Scott Tackett

Scott Tackett

Vice President - Global Access, Value & Economics, Intuitive Surgical

Panelist

Michael Neidert

Michael Neidert

VP of Business Development, Ximedica

Panelist

Dr. Jo Carol Hiatt

Dr. Jo Carol Hiatt

Emeritus, National Product Council; Chair, Inter-Regional New Technologies Committee, Kaiser Permanente

Panelist

Deepak Sahu

Deepak Sahu

Manager, Alira Health

Moderator

Seth Clancy

Seth Clancy

VP, Global Health Economics & Reimbursement, Edwards Lifesciences

Panelist